Manufacturer record
Scout Lifescience Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Scout Lifescience Pvt. Ltd (Haryana) were declared Not of Standard Quality between May 2025 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: SC2602602, Pregabalin capsules IP 300 mg (exp Jan 2028). CDTL, Mumbai (CDSCO lab) found it not of standard quality: The sample received does not conform to the I.P. 2022 standard with respect to the test for Dissolution and Description. Listed in the May 2026 alert.
Records by type
2 records linked to Scout Lifescience Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Pregabalin capsules IP 300 mg | Batch SC2602602Mfg Feb 2026 · Exp Jan 2028 | The sample received does not conform to the I.P. 2022 standard with respect to the test for Dissolution and DescriptionDissolution | CDTL, MumbaiCDSCO lab | May 2026 |
| Gabapentin Capsules IP 300mg. (GABATEC-300) | Batch SG2412559Mfg Dec 2024 · Exp Nov 2026 | Uniformity of WeightUniformity of weight/content | State Drugs Laboratory, PunjabState lab | May 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.